706 related articles for article (PubMed ID: 29956210)
1. Microbiota, Obesity and NAFLD.
Lau LHS; Wong SH
Adv Exp Med Biol; 2018; 1061():111-125. PubMed ID: 29956210
[TBL] [Abstract][Full Text] [Related]
2. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
Koukias N; Buzzetti E; Tsochatzis EA
Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
4. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease.
Jia W; Rajani C
Adv Exp Med Biol; 2018; 1061():95-110. PubMed ID: 29956209
[TBL] [Abstract][Full Text] [Related]
6. Role of gut microbiota: obesity and NAFLD.
Gangarapu V; Yıldız K; Ince AT; Baysal B
Turk J Gastroenterol; 2014 Apr; 25(2):133-40. PubMed ID: 25003671
[TBL] [Abstract][Full Text] [Related]
7. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
8. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD.
Gart E; Souto Lima E; Schuren F; de Ruiter CGF; Attema J; Verschuren L; Keijer J; Salic K; Morrison MC; Kleemann R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577415
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
Ma J; Zhou Q; Li H
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29035308
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota: Association with NAFLD and Metabolic Disturbances.
Lau E; Carvalho D; Freitas P
Biomed Res Int; 2015; 2015():979515. PubMed ID: 26090468
[TBL] [Abstract][Full Text] [Related]
11. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
He X; Ji G; Jia W; Li H
Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
[TBL] [Abstract][Full Text] [Related]
14. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
Jayakumar S; Loomba R
Aliment Pharmacol Ther; 2019 Jul; 50(2):144-158. PubMed ID: 31149745
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria.
Schwenger KJP; Bolzon CM; Li C; Allard JP
Eur J Nutr; 2019 Aug; 58(5):1771-1784. PubMed ID: 30306296
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
Han R; Ma J; Li H
Front Med; 2018 Dec; 12(6):645-657. PubMed ID: 30178233
[TBL] [Abstract][Full Text] [Related]
17. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet.
Machado MV; Cortez-Pinto H
Int J Mol Sci; 2016 Apr; 17(4):481. PubMed ID: 27043550
[TBL] [Abstract][Full Text] [Related]
18. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
Sanna C; Rosso C; Marietti M; Bugianesi E
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187365
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.
Cui Y; Wang Q; Chang R; Zhou X; Xu C
J Agric Food Chem; 2019 Mar; 67(10):2754-2762. PubMed ID: 30798598
[TBL] [Abstract][Full Text] [Related]
20. NAFLD, Helicobacter species and the intestinal microbiome.
Castaño-Rodríguez N; Mitchell HM; Kaakoush NO
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):657-668. PubMed ID: 29566909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
